New Delhi, Sept. 22 -- The global women's longevity market has an untapped incremental opportunity of USD 350 billion as women, particularly those going through perimenopause or menopause, are already spending more on health interventions but remain underserved by existing products and services, according to Boston Consulting Group (BCG).

In its Customer Insights article titled "The $350 Billion Longevity Mismatch in Women's Health," BCG said women in perimenopause or menopause spend a median USD 84 per month on longevity, compared with USD 68 for women in other life stages and USD 73 for men.

"Despite that higher rate of spending, roughly one-third say that they would be willing to spend more-a median incremental amount of USD 108 per ...